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ABSTRACT: Tissue engineering (TE)-based bone grafts are
favorable alternatives to autografts and allografts. Both biochemical
properties and the architectural features of TE scaffolds are crucial
in their design process. Synthetic polymers are attractive
biomaterials to be used in the manufacturing of TE scaffolds,
due to various advantages, such as being relatively inexpensive,
enabling precise reproducibility, possessing tunable mechanical/
chemical properties, and ease of processing. However, such
scaffolds need modifications to improve their limited interaction
with biological tissues. Structurally, multiscale porosity is advanta-
geous over single-scale porosity; therefore, in this study, we have
considered two key points in the design of a bone repair material;
(i) manufacture of multiscale porous scaffolds made of
photocurable polycaprolactone (PCL) by a combination of emulsion templating and three-dimensional (3D) printing and (ii)
decoration of these scaffolds with the in vitro generated bone-like extracellular matrix (ECM) to create biohybrid scaffolds that have
improved biological performance compared to PCL-only scaffolds. Multiscale porous scaffolds were fabricated, bone cells were
cultured on them, and then they were decellularized. The biological performance of these constructs was tested in vitro and in vivo.
Mesenchymal progenitors were seeded on PCL-only and biohybrid scaffolds. Cells not only showed improved attachment on
biohybrid scaffolds but also exhibited a significantly higher rate of cell growth and osteogenic activity. The chick chorioallantoic
membrane (CAM) assay was used to explore the angiogenic potential of the biohybrid scaffolds. The CAM assay indicated that the
presence of the in vitro generated ECM on polymeric scaffolds resulted in higher angiogenic potential and a high degree of tissue
infiltration. This study demonstrated that multiscale porous biohybrid scaffolds present a promising approach to improve bioactivity,
encourage precursors to differentiate into mature bones, and to induce angiogenesis.
KEYWORDS: tissue engineering, emulsion templating, 3D printing, decellularization, angiogenesis, polyHIPE, biohybrid
1. INTRODUCTION
Bone grafting is the second most frequent tissue trans-
plantation technique worldwide after blood transfusion.1
Autogenous bone grafts are considered to be the gold standard
as they have osteogenic, osteoinductive, and osteoconductive
properties.2−4 However, the autologous bone is mostly
harvested from the iliac crest (hip) with limited availability
and carries the risk of donor site morbidity.5 An acellular
alternative to the autograft is an allograft, which is more
abundantly available without size limitations.6 However,
allografts need to be processed and cleaned after isolation to
prevent an immune response and disease transmission.7,8
These treatments considerably affect the physical and bio-
logical properties of the bone, and the process results in grafts
with comparably poor regenerative potential and/or weak
mechanical properties depending on the treatment (deminer-
alization, deproteination, and irradiation).2,7 The regulations of
the European Union for medical devices, known as the Medical
Device Directive (MDD),9 were replaced with a new set of
Medical Device Regulations (MDR)10 in 2017, and the new
MDR will come into force on May 2020. With the new MDR,
human origin cells and tissues or derivatives will also be
considered as a high-risk medical device (class III) in addition
to those of animal origin (rule 18). Due to these regulatory
restrictions, allografts including demineralized and deprotei-
nized bone (DMB and DPB) matrices will likely have more
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restrictive approval processes and a more challenging pathway
for clinical approval.11−13
Alternatively, scaffold-based tissue engineering (TE) has
gained great attention over the last years. Scaffolds are
biodegradable porous matrices, made from natural or synthetic
materials, which aim to mimic both the biochemical and
structural features of native tissues for the regeneration of the
defect site.14−16
To date, several techniques, including electrospinning,17,18
particle leaching,19,20 freeze-drying,21,22 and additive manufac-
turing,23,24 have been widely used for fabrication of bone TE
scaffolds. Recently, emulsion templating has gained particular
attention as a scaffold fabrication technique due to its ability to
introduce up to 99% porosity with high interconnectivity into
TE scaffolds. Emulsion templating is based on creating a stable
emulsion by mixing two immiscible liquids and then
polymerizing the continuous phase. Emulsion droplets act as
a pore template during polymerization, and they are removed
afterward. When the internal phase volume (total droplet
volume) of the emulsion is greater than 74%, it is defined as a
high internal phase emulsion (HIPE). Typically, the average
pore range of polymerized HIPEs (polyHIPEs) varies from
microns to tens of microns.25 As multiple length scale porosity
is advantageous for bone regeneration when compared to
single-scale porosity,26 combining emulsion templating with
additive manufacturing enables the fabrication of hierarchically
porous scaffolds.27−30
PolyHIPEs are most commonly created using water-in-oil
(w/o) emulsions where a synthetic hydrophobic polymer is
used as the continuous phase. Synthetic polymers have various
advantages over ceramics and natural polymers, such as having
tailorable physical, chemical, and mechanical properties,
precise reproducibility, controllable biodegradability, and
processability.31−33 However, they have the disadvantage of
having comparably limited interaction with biological
tissues.34,35 One approach to overcome this limitation is the
decoration of polymeric scaffolds with ceramic particles36 or
exogenous extracellular matrix (ECM) components,37 such as
peptides,38,39 proteins, and growth factors.40,41 Nevertheless,
the incorporation of a limited number of exogenous ECM
elements is not entirely sufficient to mimic the unique
complexity of the natural ECM,42 which is a rich source of
bioactive molecules.43,44 For this reason, TE adopts cell-based
approaches in which live cells are implanted with the
biomaterial. However, the use of live cells is clinically risky,
expensive, and time consuming.45 Therefore, there has been an
increasing interest in using a cell-derived ECM to increase the
biological performance of the scaffolds while avoiding the
implantation of live cells.2,44,46−50
Recently, we reported the development of polycaprolactone
(PCL)-based polyHIPEs and demonstrated their initial cell
compatibility51 and their potential use in guided bone
regeneration.52 However, due to the hydrophobic nature of
the PCL, cell infiltration was limited unless the PCL-based
scaffolds were treated with air plasma.52 Although there is an
increasing demand for the use of emulsion-templated scaffolds
for various TE applications53,54 due to their ability to create
structures with favorable morphological properties, there are
only a limited number of studies establishing methods to
improve the cell−material interactions of polyHIPE scaffolds,
and these are limited to the incorporation of a single
biologically active agent55,56 or hydroxyapatite (HA).57,58
Herein, we aimed to consider both the structural and
biochemical requirements for the development of scaffolds for
bone regeneration and suggest an alternative approach to
improve the biological performance of w/o polyHIPEs. First,
we manufactured multiscale porous polymeric scaffolds by
combining emulsion templating and three-dimensional (3D)
printing techniques, taking advantage of the photocure ability
of the synthesized PCL (Figure 1). Subsequently, we
populated them with bone cells to decorate these scaffolds
with an in vitro cell-derived ECM. Finally, we decellularized
these constructs to obtain biohybrid scaffolds made of PCL
and the bone-like matrix. The biohybrid scaffolds were then
Figure 1. Manufacturing routes of the multiscale porous photocurable polycaprolactone (PCL) scaffolds (steps 1, 2) and multiscale porous
biohybrid scaffolds (steps 1−3). (1) Preparation of the emulsion made of photocurable PCL and water, (2) the transfer of the PCL-based high
internal phase emulsion (HIPE) into the syringe, pressure-assisted 3D printing, and simultaneous cross-linking, and (3) the culture of bone cells on
the PCL-only scaffold to be decellularized and generation of the biohybrid scaffolds.
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evaluated for their ability to support cell attachment, cell
viability, and osteogenic differentiation using human embry-
onic stem cell-derived mesenchymal progenitor cells (hES-
MPs). The angiogenic potential of the biohybrid multiscale
porous scaffolds was assessed using a well-established in vivo
assay, an ex ovo chick chorioallantoic membrane assay (CAM).
2. EXPERIMENTAL SECTION
2.1. Materials. Pentaerythritol (98%), ε-caprolactone, tin(II) 2-
ethyl hexanoate, triethylamine (TEA), methacrylic anhydride
(MAAn), photoinitiator (2,4,6-trimethyl benzoyl phosphine oxide/
2-hydroxy-2-methylpropiophenone blend), fetal calf serum (FCS),
penicillin/streptomycin, L-glutamine, trypsin, 37% formaldehyde (FA)
solution, resazurin sodium salt, glutaraldehyde, ethanol, hydrochloric
acid (HCl), sodium hydroxide (NaOH), hexamethyldisilazane
(HMDS), perchloric acid, picric acid, hematoxylin solution, eosin Y
solution, porcine gelatine, β-glycerolphosphate (βGP), ascorbic acid
2-phosphate (AA2P), dexamethasone, Triton X-100 (Triton),
deoxyribonuclease (DNAse), and Alizarin red S were purchased
from Sigma-Aldrich (Poole, U.K.). Direct Red 80 (Sirius Red) was
purchased from Fluka (Buchs, Switzerland). Chloroform, industrial
methylated spirit (IMS), dichloromethane (DCM), and methanol
(MeOH) were purchased from Fisher Scientific (Pittsburgh, PA). The
surfactant Hypermer B246-SO-M was received as a sample from
Croda (Goole, U.K.). The minimum essential α medium (α-MEM)
was purchased from Lonza (Slough, U.K.). The Quant-iT PicoGreen
(PG) dsDNA assay kit and the human fibroblastic growth factor
(hFGF) were obtained from Life Technologies (Frederick, Mary-
land). The optimum cutting temperature tissue freezing medium
(OCT-TFM) was purchased from Leica Biosystems (Newcastle,
U.K.).
2.2. Manufacturing and Characterization of the Multiscale
Porous PCL Scaffolds. Multiscale porous photocurable PCL-based
scaffolds were created in three main steps: (i) synthesis of four-arm
hydroxyl-terminated polycaprolactone (4PCL) and methacrylate
functionalization of 4PCL (4PCLMA) to make the polymer
photocurable, (ii) preparation of the emulsions made of 4PCLMA,
and (iii) simultaneous 3D printing and cross-linking of 4PCLMA-
based emulsions.
2.2.1. Synthesis and Methacrylation of 4PCL. The detailed
synthesis of the polymer, 4PCLMA, has been described elsewhere.51
Briefly, under nitrogen flow, pentaerythritol (0.088 mol) and ε-
caprolactone (0.705 mol) were added into a three-neck round-
bottomed flask, and the system was heated to 160 °C using an oil bath
while being mixed at 200 rpm. When the pentaerythritol was
completely dissolved, the catalyst, tin(II) 2-ethyl hexanoate, was
added, and the system was left overnight to form 4PCL before being
removed from the oil bath and left to cool down in the ambient
atmosphere.
4PCL was dissolved in 300 mL of DCM, and then TEA (0.705
mol) was added. Reagents were stirred, and a further 200 mL of DCM
was added to ensure everything was dissolved. The flask was placed in
an ice bath. MAAn (0.705 mol) was dissolved in 100 mL of DCM and
transferred into a dropping funnel (∼1 drop/s). When the MAAn was
completely dispensed, the ice bath was removed, and the system was
maintained at room temperature (RT) for 68 h while being mixed. It
was then washed with HCl solution, and then with deionized water
(dH2O) to remove TEA, MAAn, and salts formed. Almost all solvents
were evaporated using a rotary evaporator. Three methanol washes
were applied, and any remaining solvent was removed using a rotary
evaporator. 4PCLMA was stored in the freezer (−20 °C) for further
use.
2.2.2. Characterization of 4PCL and 4PCLMA. To confirm the
structure of 4PCL and 4PCLMA and also to measure the degree of
methacrylation, proton (1H) nuclear magnetic resonance (NMR)
spectroscopy analysis was performed on an AVANCE III
spectrometer at 400 MHz. The spectra were recorded using an 8.2
kHz acquisition window, with 64k data points in 16 transients with a
60 s recycle delay (to ensure full relaxation). Deuterated chloroform
was used as a diluent (CDCl3). Spectra were analyzed using the
MestReNova software. Chemical shifts were referenced relative to
CDCl3 at 7.26 ppm.
The weight average molecular weight (Mw) and number average
molecular weight (Mn) distributions of 4PCLMA were determined
using a Viscotek GPCmax VE200 gel permeation chromatography
(GPC) system with a differential refractive index detector (Waters
410). Tetrahydrofuran was used as the eluting solvent at a flow rate of
1 mL/min at 40 °C, and polystyrene standards were used as the
calibration sample.
2.2.3. Preparation of 4PCLMA-Based HIPEs. Throughout this
study, the only polymer used was 4PCLMA, and it has been entitled
as PCL in the rest of the text except Section 3.1 unless otherwise
stated. PCL (0.2 g) and 10% (w/w) surfactant were added into a glass
vial (⌀ = 25 mm) and heated to 40 °C to dissolve the surfactant and
left for cooling. The chloroform/toluene solvent blend (40/60 (w/w),
0.3 g) was added to the PCL−surfactant mixture and mixed at 375
rpm using a magnetic stirrer for 1 min at RT. Once the homogeneous
mixture was created, 2 mL of water was added dropwise for PCL
HIPEs (89% internal phase volume), and the emulsion was mixed for
a further 5 min at 375 rpm and 5 min at 1000 rpm.
2.2.4. Viscosity Measurements. AR2000 (TA Instruments, New
Castle, DE, USA) was used to characterize the viscosity of the PCL
HIPEs. Steel cone plates (40 nm, 2°) were used with a gap of 55 μm
at 25 °C. The sample (0.6 mL) was injected, and a continuous ramp
step was applied with a shear between 0.01 and 10 s−1 using log mode
and 50 points per decade.
2.2.5. Three-Dimensional (3D) Printing and Polymerization of
PCL-Based HIPEs. A 10 × 10 × 1.4 mm3 tetragonal prism was
designed using Solidworks (2012) and saved as a standard tessellation
language (.stl) file format. This file was imported into the Repetier
host to convert .stl format to .gcode format, which is a layer by layer
design of the scaffold to make it recognizable by the printer. During
the conversion, the following parameters were set: layer height; 100
μm, infill; 36% rectilinear, and speed; 13 mm/s.
The Gcode file was imported into the Bioprint software, and the
PCL-based HIPE was loaded into a syringe with a 30G precision tip
needle. The syringe was connected to the compressor line and placed
into a three-axis dispensing control system at RT. The pressure was
set to 20 psi, however, slightly adjusted throughout the process for the
best results. Multiscale porous PCL scaffolds were prepared by
simultaneous printing and cross-linking of the PCL-based HIPE with
the help of the integrated light-emitting diode (LED) lamp of the
printer (Biobot1, Allevi, Philadelphia, PA).
2.2.6. Morphological Investigation of the Multiscale Porous PCL
Scaffolds. Scanning electron microscopy (SEM) was used to
investigate the microarchitecture of the scaffolds. Samples were gold
sputter-coated in 15 kV for 2.5 min to increase conductivity. A FEI
Inspect F SEM (Philips/FEI XL-20 SEM, Cambridge, U.K.) was used
with 10 kV power. Randomly 20 pores, 20 struts, and 50 micropores
were selected, and measurements were taken. A statistical correction
factor (2/√3) was applied to micropore measurements to adjust the
underestimation of diameter because of uneven sectioning.59 The
degree of interconnectivity was calculated by dividing the average
window size by the average pore size (d/D),51,60 and the degree of
openness was calculated by dividing the open surface area to the total
surface area.34,61 The window diameters of 50 micropores (426
windows in total) were measured.
2.3. Manufacturing of the Biohybrid Scaffolds via In Vitro
Generated ECM Matrix Deposition on Multiscale Porous PCL
Scaffolds. Biohybrid scaffolds, made of PCL and bone ECM, were
manufactured in three main steps; (i) manufacturing of the multiscale
porous PCL scaffolds as described in Section 2.2, (ii) cellularization,
and (iii) decellularization of these scaffolds.
2.3.1. Cellularization of the Multiscale Porous PCL Scaffolds with
Bone Cells. Multiscale porous PCL scaffolds were washed with 100%
ethanol four times (24 h each) to remove any remaining
contaminants of the surfactant, the solvent, or the uncured material.
Then, they were left in 70% ethanol for 2 h and then transferred into
phosphate-buffered saline (PBS) in sterile conditions; four PBS
ACS Applied Materials & Interfaces www.acsami.org Research Article
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washes were applied in 24 h. α-MEM supplemented with 10% FCS, 2
mM L-glutamine, and 100 mg/mL penicillin/streptomycin was used
as a basal cell culture media (BM). Scaffolds were conditioned with
BM for 2 h in the incubator. Murine osteoblast/osteocyte-like cells
(MLO-A5s) were defrosted into gelatine-coated T75 flasks and
cultured until 90% confluence. MLO-A5s were expanded, trypsinized,
counted, and centrifuged. The cell pellet was resuspended in fresh BM
media (25 000 cells/20 μm). The media in the well plate was
aspirated, and 20 μm of the cell suspension was placed on the whole
surface of each scaffold homogenously and left for 2 h in an incubator
(37 °C, 5% CO2) for cell attachment. During this time, to prevent
cells from drying out and keep the inside of the well humid, 4 mL of
BM media was injected into the spaces between the wells. After 2 h, 2
mL of BM media was supplied into each well and incubated
overnight. On the following day, scaffolds were transferred into a fresh
well plate and incubated with supplemented media (SM) consisting of
BM with 50 μg/mL AA2P and 5 mM βGP. Cell culture media was
changed every 2−3 days.
2.3.2. Decellularization of the Multiscale Porous PCL Scaffolds
Populated with Bone Cells. Three different decellularization methods
were used for devitalization of multiscale porous PCL scaffolds
cultured with MLO-A5s: freezing and thawing (ft), Triton and
ammonia (ta), and DNAse. Four different combinations of these
protocols were tested: (i) ft only, (ii) ft + ta, (iii) ft + DNase, and (iv)
ft + ta + DNAse, and they were compared in terms of their efficiency
of DNA removal. Before applying each decellularization protocol,
culture media was removed, and scaffolds were washed twice with
PBS. Each method is described in the following section. At the end of
the application of a decellularization method, scaffolds were washed
with warm (37 °C) PBS three times to remove the cellular
component. Combined protocols were applied by following the
individual protocols in order.
The method of ft is categorized as mechanical decellularization, and
it is applied by alternating the temperature between freezing
temperatures and biological temperatures. The ft technique leads to
lysis of cells with the help of intracellular ice crystals. Although this
technique maintains ECM properties, its usage as a single-step
method has been found to be inefficient based on DNA removal.62
Herein, we applied consecutive three freeze−thaw cycles. For one
freeze−thaw cycle, scaffolds were left at −80 °C for 15 min and
transferred into a 37 °C water bath for 30 min.
Triton is a nonionic detergent and used as a chemical
decellularization agent, it disrupts lipid−lipid and lipid−protein
interactions, and it is less damaging to the ECM structure in
comparison with ionic detergents such as sodium dodecyl sulfate.
Triton is commonly used with ammonium hydroxide (triton +
ammonium hydroxide: ta), which is a base, and it also solubilizes the
cell membrane and nuclear components.63 Scaffolds were incubated in
a 1 mL mixture of Triton (0.5%) and ammonium hydroxide (20 mM
in PBS) for 10 min at 37 °C, and the solution was removed afterward.
DNAse is as an enzymatic decellularization agent, used for breaking
down of DNA fragments and removal of the nucleotide lysis of the
cell membrane with another complementary method. There are no
reported adverse effects of DNAse on ECM.64−66 Scaffolds were
incubated in 1 mL of the DNAse solution (0.2 mg/mL) in an
incubator for an hour.
2.4. Cellularization of the Biohybrid Scaffolds with
Mesenchymal Progenitors. Multiscale porous PCL-only scaffolds
and biohybrid scaffolds were seeded with hES-MPs (Cellartis,
Sweden) for testing their biological performance. hES-MPs were
defrosted into gelatine-coated T75 flasks and cultured until 90%
confluence with BM. During the expansion of cells, BM was
supplemented with hFGF at 4 ng/mL to stop differentiation of cells
to other cell types. After the expansion of cells, they were trypsinized,
counted, and centrifuged. The cell pellet was resuspended in fresh
media (25 000 cells/20 μm). The media in the 24-well plate was
aspirated, and 20 μm of the cell suspension was placed on the whole
surface of each scaffold homogenously and left for 2 h in an incubator
(37 °C, 5% CO2) for cell attachment. During this time, to prevent
cells from drying out and keep the inside of the well humid, 4 mL of
BM media was injected into the spaces between the wells. After 2 h, 2
mL of BM media was supplied into each well and incubated
overnight. On the following day, scaffolds were transferred into the
fresh well plate and incubated with osteogenic media (OM)
consisting of SM with 100 nM dexamethasone. Cell culture media
was changed every 2−3 days.
2.5. Biological Characterization of PCL-Only and Biohybrid
Scaffolds. 2.5.1. Cell Viability Assay. Resazurin reduction (RR)
assay was applied to measure the cellular metabolic activity and
estimate the cell viability on scaffolds. Resazurin solution (non-
fluorescent, blue) is reduced by the cells and forms resorufin
(fluorescent, pink), which is detectable by a fluorescence plate reader.
Resazurin stock solution (in dH2O, 1 mM) was diluted to 100 μM in
culture media to make the resazurin working solution. Resazurin
working solution (1 mL) was added into each well, and the scaffolds
were transferred into a fresh well plate using sterile forceps. The well
plates were protected from light and incubated for 4 h at 37 °C. From
each scaffold, triplicate samples of 200 μL of the reduced solution
were added to a 96-well plate. This was measured three times using a
spectrofluorometer (FLX800, BioTek Instruments, Inc.) at an
excitation wavelength of 540 nm and an emission wavelength of
630 nm. RR assay was performed at days 1, 7, 14, 21, and 28 of
culture for both MLO-A5s and hES-MPs using a fresh scaffold for
each time point.
2.5.2. Measuring DNA Content. To find the cell seeding
efficiencies of MLO-A5s and hES-MPs and to measure the remaining
DNA content following the decellularization of the scaffolds, a Quant-
iT PicoGreen dsDNA assay kit was used. Scaffolds were washed with
PBS three times, and 500 μL of cell digestion buffer was added and
incubated for 30 min. The three freeze−thaw cycles were applied, and
scaffolds were vortexed for 15 s. Scaffolds were removed, and the
remaining buffer was mixed homogenously. The sample and the
Picogreen working solution were transferred into a 96-well plate (1:1)
as triplicates. The plate was covered with an aluminum foil and
incubated at RT for 10 min with gentle shaking. The resulting
solution was read by using a spectrofluorometer at an excitation
wavelength of 485 nm and an emission wavelength of 528 nm.
2.5.3. Measuring ECM Deposition. Alizarin red (AR) and Sirius
red (SR) staining was conducted to measure calcium and collagen
deposition, respectively. Culture media was removed, and scaffolds
were washed with PBS. Scaffolds were transferred into 1 mL of 3.7%
FA and left for 2 h at RT. FA was removed, and scaffolds were washed
twice with dH2O. AR powder was dissolved in dH2O at 1% (w/v) in a
water bath and filtered to remove particles to make Alizarin red
solution (ARS). SR powder was dissolved in saturated picric acid (1%
(w/v)) to form Sirius red solution (SRS) and filtered to ensure no
particles remained. Scaffolds were submerged in 1 mL of SRS or ARS
and left for 1 h. The solution was removed, and scaffolds were washed
every 5 min with dH2O while being mixed until the water remains
clear. Scaffolds were submerged with a known volume of 5%
perchloric acid or 0.2 M NaOH/MeOH (1:1) to destain the AR and
SR, respectively, for 30 min with gentle orbital shaking. Destain
solutions (150 μL) in triplicates were transferred into a clear 96-well
plate and read at an absorbance of 405 nm.
2.5.4. SEM of Biological Samples. Scaffolds were washed three
times with PBS after removing culture media and fixed in 2.5% (in
PBS) glutaraldehyde at RT for 1 h to preserve the cell structure. They
were rinsed with PBS for 15 min (three times) and soaked in dH2O
for 5 min. Following this, samples were subjected to serial ethanol
washes to be dehydrated (35, 60, 80, 90, and 100% for 15 min for
each concentration). Finally, samples were treated with drying agent
HMDS/ethanol (1:1) for 1 h and 100% HMDS for 5 min before air
drying. Samples were gold-coated and visualized using methods
described in Section 2.2.6.
2.5.5. Energy-Dispersive X-ray (EDX) Analysis. Biological samples
were prepared in the same way as described in Section 2.5.4 and
carbon-coated. SEM microscope (FEI Inspect F50 (Philips/FEI XL-
20 SEM, Cambridge, U.K.)) with an energy-dispersive analyzer was
used with 10 kV power for scanning and EDX elemental mapping.
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2.5.6. Ex Ovo CAM Assay. Fertilized eggs (Henry Stewart Co. Ltd.,
U.K.) were cracked, and embryos were transferred into weighing
boats inserted inside the Petri dishes at embryonic development day
(EDD) 3. The ex ovo chick embryos were cultured in an incubator at
38 °C from EDD 3 to EDD 8 without any further modification. At
EDD 8, PCL-only scaffolds (negative control), hybrid scaffolds, and
scaffolds cultured with MLO-A5s (4 weeks) (positive control) were
cut by using a sterile punch (⌀ = 6 mm) and placed on CAM and
incubated. At EDD 14, digital images were taken, and embryos were
sacrificed by cutting their arteries. Scaffolds were isolated with a 1 cm
CAM margin for histological assessment.
2.5.7. Morphometric Quantification of the Angiogenesis. At
EDD 14, the macroimages of the scaffolds on CAM were taken with a
digital microscope (Figure 2A). Four digital images from each group
were quantified using a modified version of a well-established
method.60,61,67 A 10 mm × 10 mm region was cropped in each
image. To improve the discernability of the blood vessels, the
following parameters were set to all images in Adobe Photoshop (PS)
CS6; brightness and contrast; −50/10, unsharp; 50/10/0, smart
sharpen; 100/5 with Gaussian blur and reduced noise; 5/0/0/50
(Figure 2B). A new layer was created in PS, and all discernable vessels
were drawn digitally using a Wacom Intuos Pro Medium Tablet with
a 2 pixels size-hard round brush (Figure 2C).
The layer created for the drawing of blood vessels was exported
from PS and imported into ImageJ (Figure 2D). The image was
converted to binary, inverted, and saved (Figure 2E). The number of
blood vessels was calculated by counting the total count of the vessels
touching the border of the scaffolds. The total vessel length and the
total number of junctions were quantified using Angiotool (National
Cancer Institute, MD) (Figure 2F).
2.5.8. Haematoxylin and Eosin (H&E) Staining. Haematoxylin and
eosin (H&E) staining on polyHIPE scaffolds has been described in
detail elsewhere.51 Briefly, scaffolds isolated from CAM were washed
with PBS and fixed in 3.7% FA. Scaffolds were transferred into
cryomolds filled with freezing media and frozen. Sections with 5−8
μm thickness were sliced on glass slides using the cryostat (Leica
CM1860 UV, Milton Keynes, U.K.). Slides were stained with
hematoxylin and eosin for 1.5 and 5 min, respectively. After washing
with dH2O, slides were dehydrated in IMS and dunked into xylene.
The slides were then mounted with DPX, and the images were
captured using a light microscope (Motic BA210, China).
2.6. Statistical Analysis. Statistical analysis was carried out using
GraphPad Prism. One-way (Figure 7A, Figure 9D-F) or two-way
(Figure 6B, Figure 8B) analysis of variance (ANOVA) with multiple
comparisons was performed to find the statistical significance. Where
relevant, n values are given in figure captions. Error bars indicate
standard deviations in the graphs unless otherwise stated.
3. RESULTS AND DISCUSSION
3.1. Synthesis and Characterization of the Photoc-
urable PCL. The chemical structure and 1H NMR spectra of
4PCL and 4PCLMA are given in Figure 3A−C,E. The peaks of
the hydroxyl ends (−OH) are framed with the dark gray box
and labeled with “a”. These peaks represent the ends that were
not methacrylated. The peaks of the methacrylate group are
framed with yellow boxes and labeled with “b, c, and d”. From
these results, it is clear that all of the hydroxyl ends that
showed up in 4PCL have been converted to methacrylate ends
following the methacrylation reaction. This suggests that the
4PCLMA used in this study is 100% methacrylated. It was
reported that the higher degree of methacrylation cross-links
the photocurable monomers to a higher degree, and this results
in a mechanically stronger material.68−70 GPC results showed
that the Mw and Mn values were 2069 and 1771 g/mol,
respectively, and the dispersity index was calculated as 1.17
(Mw/Mn).
PCL is a synthetic polymer that has drawn considerable
attention for use in the fabrication of TE scaffolds due to
having various advantages such as being cell-compatible,
bioresorbable, and having an ease of processability.71 Also,
PCL has been approved by the Food and Drug Administration
(FDA) for its use in several medical products, such as drug
delivery devices and sutures.72 However, there are a limited
number of studies that use photocurable PCL in biomedical
applications.51,73−75 Photocurable polymers need to have
photoreactive groups such as acrylates or methacrylates to be
Figure 2. Steps of the morphometric quantification of angiogenesis: (A) macroimage as captured, (B) improved image using Photoshop (PS), (C)
drawn discernable blood vessels, (D) exported blood vessel layer from PS, (E) binary and inverted images in ImageJ, (F) analyzed image using
Angiotool.
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able to be cross-linked via UV and to create a polymer network
in the presence of the photoinitiator (Figure 3D).74 However,
as commercial PCL does not contain these photoreactive
groups, photocurable PCL needs to be synthesized in-house.
Photocurable polymers can be polymerized within seconds,
they have higher solvent resistance over the non-cross-linked
Figure 3. Synthesis scheme of four-arm photocurable polycaprolactone: (A, B) monomer and the initiator were used for the synthesis of hydroxyl-
terminated four-arm polycaprolactone (4PCL). (B,C) 4PCL was methacrylated (4PCLMA). (D) Schematic demonstration of the photocured
(UV-cross-linked) network showing a building block made of 4PCLMA. (E) 1H NMR spectrum of 4PCL, 4PCLMA, and relative assignments.
Dark gray region: peaks of the hydroxyl group, light yellow regions: peaks of the methacrylate group, which only showed up after methacrylation
reaction while they are absent in 4PCL.
Figure 4. (A) Viscosity of the polycaprolactone (PCL)-based high internal phase emulsion (HIPE) prepared to be used in the printing process. (B)
Three-dimensional (3D) printing and simultaneous cross-linking of PCL HIPE. (C) Morphological characterization (nmacropore = 20, nstrut = 20, and
nmicropore = 50) and (D) micropore size distribution of the scaffolds in terms of the diameter frequency and the volume frequency.
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polymers, and they do not need the high temperatures, which
are required for thermally initiated polymerization.76 Due to
being processable at mild operational conditions, photocurable
polymers are considered to be good candidates for use in 3D
printing applications.77,78
3.2. Fabrication of Multiscale Porous PCL Scaffolds
by a Combination of Emulsion Templating and 3D
Printing. There are two main issues that should be considered
in the design of emulsion inks for the 3D printing process: (i)
emulsions need to have a viscosity high enough to hold the
printed shape until gelation (cross-linking), (ii) emulsion-
templated scaffolds need to have a pore size distribution that
does not limit cell infiltration. It is essential to highlight the fact
that in w/o emulsions, emulsion viscosity is inversely
proportional to the size distribution of the water droplets.79
Thus, the viscosity of the emulsion should be high enough for
the successful printing of the emulsion inks and low enough to
enable the manufacturing of the scaffolds with pore size ranges
that allow cell infiltration.
Both viscosity and pore size can be tuned by controlling the
internal phase volume, the type/amount of the surfactant used,
the process temperature, and mixing conditions.79−82 Sears et
al. reported 3D printing of acrylate-based emulsion inks,
prepared by mixing up to 2500 rpm. In their study, the
rheology of the inks was optimized for high accuracy printing
of the emulsion to fabricate lattice design scaffolds for bone
Figure 5. SEM micrographs of (A-D) multiscale porous PCL-only scaffolds immediately after manufacture, (E−G) after 1 week of MLO-A5
culture, (H−J) after 4 weeks of MLO-A5 culture, (K−M) after the decellularization process (biohybrid scaffold), (N−P) after 4 weeks of the
culture of hES-MPs on the biohybrid scaffolds. First column macroview of the scaffold, the second column shows the single pore, and the third
column shows the microsurface of the scaffold at different stages of the experiment.
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TE, but the micropore size was not reported.30 Yang et al.
reported the use of mechanical shaking for the emulsification
process and demonstrated the successful fabrication of 3D-
printed emulsion-templated scaffolds with an average micro-
pore size of 20 μm.27
As relative viscosity increases with the increasing volume
fraction of the dispersed phase,83,84 we maximized the inner
phase volume. The maximum water volume achieved was 89%
where a further increase in the water volume beyond that
resulted in phase separation of the emulsion at the reported
process conditions. PCL-based HIPE showed shear-thinning
behavior, which enables their extrusion through the nozzle
with applied pressure85 (Figure 4A). Throughout the printing
process, no phase separation was observed in PCL-based
HIPEs. Similarly, we have previously shown the stability of the
photocurable PCL-based HIPEs over 5 days.51
Pore size is one of the critical features that affect the
biological performance of bone TE scaffolds in terms of cell
attachment, infiltration,86,87 bone formation,88−90 differentia-
tion,87,91 osseointegration,92,93 and vascularization.89,93 Re-
cently, multiscale porous scaffolds, developed to mimic the
hierarchical structure of the natural bone, have attracted great
attention,94−97 and multiscale porosity has been found to be
more favorable for bone regeneration compared to single-scale
pore designs.26,89 While macropores encourage vascularization
and osteointegration,96 incorporation of microporosity into
scaffolds has been reported to provide grooves and roughness
on the surface topology of the scaffolds, which facilitate cell
adhesion.89,98 These also provide a larger surface area, thereby
higher protein absorption.99,100 The reported optimal micro-
and macropore size ranges for bone TE scaffolds in the
literature are conflicting, as the compositions of the scaffolds,
pore shapes, mechanical properties, cell types used in the
experiments, test conditions, and the duration of the
experiments vary.89,101 However, in general, scaffolds with
macropores sized over 300 μm and micropores sized less than
10−50 μm have been recommended and used by many
researchers for bone regeneration studies.89,96,97
In this study, the multiscale porous PCL-only scaffolds were
easily fabricated by 3D printing and the simultaneous cross-
linking of PCL HIPEs (Figure 4B). No post-process was
required to polymerize the PCL scaffolds. The average sizes of
the macropores, struts, and micropores were measured as 315
± 25, 325 ± 18, and 8 ± 5 μm (Figure 4C,D), respectively.
Micropores of the scaffolds exhibited open-cell morphology
which is characterized by the presence of windows on the walls
of the pores. Average window diameter was measured as 1.6
μm, both the degree of openness and the degree of
interconnectivity of the polyHIPEs were measured as 0.2,
which is in line with the reported values in the literature.
The microporous architecture of the scaffolds was found to
be different at the surface of the struts compared to within the
core of the scaffolds (Figure 5C,D). This is because the surface
of the polyHIPE is known to be affected by the contact
materials such as the mould or air, and monoliths result in
different morphologies at the surface and the cross-section.52
However, as the pores on the surface still exhibited an open
porosity, we believe this morphological difference did not pose
a limitation to our system. A similar structural difference also
can be seen in the study reported by Binks et al. for 3D-printed
non-photocurable PCL polyHIPE scaffolds.27
3.3. Generation of the Biohybrid Scaffolds and
Evaluation of Their Biological Activity. 3.3.1. Bone ECM
Deposition on the Multiscale Porous PCL Scaffolds. MLO-
A5 cells are late-stage osteoblasts (pre-osteocytes), which have
been shown to mineralize in 3 days in supplemented media
and to rapidly produce the bone-like matrix. We use this
mouse cell line in the proof-of-concept of this study as they
have been previously reported to produce mineral (in culture),
which has similar characteristics to that of the native bone as
measured by Fourier transformed infrared spectroscopy.102
Despite the long incubation time for cell seeding (2 h) and
conditioning of the scaffolds with media, the seeding efficiency
of MLO-A5s was found to be less than 15% using a DNA
quantification assay (Figure 6A). This is likely because (i) the
macroporosity of the scaffolds caused the cell suspension to
drain from the scaffolds to the tissue culture plate (TCP) and
(ii) the hydrophobicity of PCL limiting the cell−surface
interactions and inhibiting cell attachment. Recently, we have
shown that air plasma treatment can increase cell attachment,
viability, and infiltration on hydrophobic polyHIPE scaf-
folds.29,51 However, in this study, air plasma treatment was
not used to be able to show the single impact of ECM
deposition on the biological activity of the scaffolds.
Although the culture began with low cell numbers on
multiscale porous PCL scaffolds at day 1, the cell viability of
MLO-A5s dramatically increased from day 1 to day 7 and
continued to increase until day 28 (Figure 6B). Cell viability of
MLO-A5s cultured on TCP increased steadily from day 1 to
day 14 and then remained stable, likely due to reaching
confluence in the limited two-dimensional (2D) growth area
that TCP provided.
Mineral and collagen deposition of MLO-A5s cultured on
multiscale porous PCL-only scaffolds showed a dramatic
increase from day 14 to day 28 (Figure 6C,D). There was a
progressive population of bone cells on the struts and the pores
of the scaffold (Figure 5A−J). At week 4, complete coverage of
the surface with cells and deposited ECM material (Figure 5H)
containing mineralized nodules (Figure 5J) was observed.
Figure 6. (A) Cell seeding efficiency of MLO-A5s on multiscale
porous PCL-only scaffolds (n = 5). (B) Metabolic activity (n = 5),
(C) mineral, and (D) collagen deposition of MLO-A5s on multiscale
porous PCL-only scaffolds and TCP as control over 28 days (n = 3, *:
p < 0.05, ns: not significant, p > 0.05).
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3.3.2. Decellularization of the Multiscale Porous PCL
Scaffolds Populated with Bone Cells. The fundamental aim of
the decellularization process is to remove the genetic material,
which may trigger an immune response103 while preserving
ECM components.64 There are various decellularization
methods described in the literature.64 Depending on the target
tissue, the cell line, and the scaffold design, various
combinations of these methods have been performed to
disintegrate the cell membrane and to remove the cellular
material.104 While multiple methods are combined and longer
washing steps are applied for decellularization of the whole
organs or tissues,64,105 less harsh methods are used for
decellularization of the in vitro generated ECM on scaf-
folds.2,46−50
Herein, we compared the efficiency of ft, ft + ta, ft + DNAse,
and ft + ta + DNAse treatments in terms of DNA removal, and
the remaining DNA amounts were measured as 26, 14, 5, and
4% of the total amount of initial DNA, respectively (Figure
7A). There was no significant difference found in the
remaining DNA contents of the groups decellularized via ft
+ DNAse and ft + ta + DNAse. Thus, ft + DNAse treatment
was chosen as the decellularization method for this study due
to its ability to remove DNA up to 95%.
Following the decellularization, 88 and 77% of the deposited
calcium and collagen amounts were found to be preserved on
biohybrid scaffolds (Figure 7B). The ft + DNAse method was
successful in the removal of 95% of the total DNA while
preserving most of the collagen and mineral deposited onto the
scaffolds. Although the macropores were covered with MLO-
A5s after 4 weeks of culture, the multiple washing steps of the
decellularization process seemed to disrupt the ECM layer
covering the macropores and resulted in a mostly open porous
structure (Figure 5K−M). EDX analysis of the biohybrid
scaffolds also showed that the remaining elemental composi-
tion consisted of mostly calcium (Ca) and phosphorus (P), the
main inorganic constitutes of the native bone tissue (Figure
7C−G). Some trace elements, such as sodium (Na),
magnesium (Mg), silicon (Si), and sulfur (S), were also
found within the deposited ECM. The small peak that
corresponds to the presence of P detected on the PCL-only
scaffolds is likely to come from the photoinitiator that joined
the structure of the polymer during free-radical polymerization.
3.3.3. Evaluation of the Biological Activity of the
Biohybrid Scaffolds Using hES-MPs. hES-MPs are able to
differentiate into osteogenic, chondrogenic, and adipogenic cell
lines. The gene expression profile of hES-MPs is similar to
human mesenchymal stem cells (MSCs), but they have a
higher proliferation rate.106,107 In this study, they were used as
a representative of osteoprogenitor cells to understand the
initial steps that may occur when human osteoprogenitors
encounter biohybrid scaffolds in vivo.
Seeding efficiencies of hES-MPs were found to be 11 and
34% on PCL-only and biohybrid scaffolds, respectively (Figure
8A). ECM deposition onto the polymeric scaffold increased
the initial cell attachment up to 3-fold compared to the PCL-
only scaffold. Cell adhesion is a process that is modulated by
surface receptors, integrins that can recognize ECM
proteins.108 Similarly, the presence of ECM proteins on the
surfaces has been reported to have a positive impact on cell
attachment and growth.46,109,110 Also, the remaining ECM
deposited on the surfaces has been reported to increase the
roughness of the surfaces of the substrates, and this is likely to
enhance the initial cell attachment.111
While hES-MPs cultured on PCL-only scaffolds barely
survived over 28 days, the cell viability of hES-MPs cultured on
Figure 7. (A) Comparison of the various decellularization techniques
in terms of remaining DNA content (n = 3), (B) Calcium and
collagen content of the scaffolds cultured with MLOs for 4 weeks
(blue) and scaffolds that are decellularized (purple) (n = 3, ns: not
significant, p > 0.05), (C) EDX spectrum of the decellularized scaffold
showing the peaks of carbon (C), phosphorus (P), calcium (Ca), and
oxygen (O), (D) SEM image of the decellularized scaffold, (E−G)
EDX elemental mapping of Ca (blue), P (pink), and merged mapping
(Ca and P), respectively.
Figure 8. (A) Seeding efficiencies of human embryonic stem cell-
derived mesenchymal progenitor cells (hES-MPs) on polycaprolac-
tone (PCL)-only and biohybrid scaffolds (n = 6), (B) the metabolic
activity (n = 6), (C) mineral (n = 3), and (D) collagen deposition of
hES-MPs on PCL-only, biohybrid scaffolds, and on the tissue culture
plate (TCP) as a control in 28 days culture (n = 3, *: p < 0.05, ****:
p < 0.001, ns: not significant, p > 0.05).
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biohybrid scaffolds showed a significant increase from day 14
to day 28 (Figure 8B). The viability of hES-MPs growing on
TCP increased until day 14, and cells started to detach from
the surface of the TCP after that point.
Various properties, such as biochemical composi-
tion,17,112,113 morphology,114 and mechanical properties,115
of the substrates have been shown to affect the osteogenic
activities of stem cells. Similarly, in our system, the amounts of
newly formed ECM, collagen, and mineral by hES-MPs on
biohybrid scaffolds were dramatically higher compared with
ECM deposition on PCL-only scaffolds (Figure 8C, D).
Although hES-MPs cultured on both PCL-only and the
biohybrid scaffolds were supplemented with OM, hES-MPs on
PCL-only scaffolds were not able to deposit a significant
amount of calcium. Similar to our findings, Datta et al.
previously showed that in vitro cell-generated ECM decoration
on titanium implants stimulates the differentiation of rat
marrow stromal cells even in the absence of osteogenic
supplements, although this effect is shown to increase with the
supplementation of osteogenic factors.46 Baroncelli et al. have
shown more than a 20-fold increase in the calcium deposition
of MSCs on ECM-decorated substrates compared to plain
ones.111 Tour et al. also reported that decoration of HA
scaffolds with in vitro generated ECM obtained from both rat
osteoblasts and rat fibroblasts enhanced the osteogenic activity
and reduced the inflammatory response in vivo.50
Figure 9. Evaluation of the angiogenic potential of polycaprolactone (PCL)-only, PCL-only populated with murine long bone osteocyte cells
(MLO-A5s), and biohybrid scaffolds using chick chorioallantoic membrane (CAM) assay. (A−C) Macroimages were taken on embryonic
development day 14, (D−F) quantification of the number of blood vessels, total vessel length, and the total number of junctions. (n = 4, *: p <
0.05, **: p < 0.01, ***: p < 0.005, ****: p < 0.001, ns: not significant, p > 0.05.) (G−O) Histological evaluation of the scaffolds isolated from
CAM. (Black arrows indicate the blood vessels).
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3.3.4. Evaluation of the Angiogenic Activity of the
Biohybrid Scaffolds Using CAM Assay. CAM assay is a
rapid (2 weeks) and a cost-effective bioassay, which has been
widely accepted as an in vivo platform to investigate initial
tissue response to biomaterials and angiogenic factors.60,116 In
practice, it is comparatively easier than other in vivo assays,
most of which require several surgical procedures. The CAM
assay allows direct visualization of newly formed blood vessels
in the area of implantation throughout the duration of the
experiment when performed ex ovo (shell-less).117
Angiogenesis and host tissue integration are crucial for
osseointegration of bone grafts after implantation.118−120
Herein, we used ex ovo CAM assays to evaluate: (i) initial in
vivo response, (ii) angiogenic response, and (iii) the degree of
cell and tissue integration with scaffolds.
Angiogenic effects of various cell types, including adipose-
derived MSCs,67,121 human dermal microvascular endothelial
cells,122 and fibroblasts,121,122 on CAM have previously been
reported. However, it has not been studied whether the cells
cause the angiogenic effect or the ECM they deposit during the
implantation period. In our CAM assay experiments, PCL
scaffolds populated with MLO-A5 were used as the positive
control and PCL-only scaffolds were used as a negative control
as these should not possess any angiogenic properties.
The ex ovo CAM assay demonstrated that ECM deposition
and the presence of MLO-A5s did not show a negative impact
on the embryo survival rate, which was above 70%. Scaffolds
with either ECM or live MLO-A5s significantly increased the
number of blood vessels, total vessel length, and the total
number of junctions in comparison to the PCL-only group
(Figure 9A-F). Scaffolds cultured with MLO-A5s showed a
better performance in terms of all of the three measurements
mentioned above; however, only the number of blood vessels
was significantly different from other groups.
At EDD 14, while isolating scaffolds, it was not possible to
peel the CAM layer from the scaffold, and there was complete
integration of CAM with scaffolds in all three groups (Figure
9G−O). However, while there was limited cell infiltration from
CAM to the PCL-only scaffold, the ECM containing group
showed higher infiltration through both macro- and micro-
pores, whereas the highest infiltration was observed in the cell
containing group. Additionally, blood vessels growing in the
macropores were clearly detectable in the ECM and cell-loaded
groups.
Pham et al. have also previously shown that in vitro
generated ECM increased the vascularization of the constructs
implanted intramuscularly in a rat animal model.2 They
hypothesized that it is potentially because of the contribution
of the angiogenic factors that are released into the in vitro
deposited ECM. Although future investigations are necessary
to validate the composition of the ECM present here in terms
of growth factors, angiogenic factors, and cytokines, our
conclusions are in line with their hypothesis. Additionally, we
also consider the contribution of the trace elements whose
presence was verified using EDX analysis. Zhang et al. reported
that Mg-, Ca-, and Si-containing ceramic scaffolds improved
vascularization and bone regeneration in vivo.123 Similarly, Mg
is reported to be a vital trace element in the bone, and its role
in bone regeneration and vascularization has been investigated
by many other researchers.124−126
Accordingly, the findings from the quantification of both
macro- and histology images support the notion that ECM
deposition increased the angiogenic activity and tissue
infiltration of the PCL scaffolds. Although this response was
slightly higher when the cells were maintained alive in the
scaffolds, this needs to be weighed against the difficulties and
limitations of implanting live cells in a clinical situation.
4. CONCLUSIONS
In this study, we developed biomimetic and biohybrid scaffolds
for bone TE. Hierarchically porous PCL-based scaffolds were
successfully fabricated by combining emulsion templating and
3D printing techniques. Following the culture of bone cells on
these scaffolds for bone ECM deposition, the decellularization
procedure successfully removed the 95% of the DNA, while
preserving most of the collagen and mineral on the scaffolds.
By testing the scaffolds for their ability to support
osteoprogenitors, it was revealed that bone-derived ECM
improved cell attachment, proliferation, and ECM deposition
ability of hES-MPs. Bone-derived ECM also significantly
improved the angiogenic activity in ex ovo CAM assay where
the blood vessels were found to be growing through the
macropores of the scaffolds on CAM. The results suggested
that biohybrid scaffolds made of PCL polyHIPE and cell-
generated ECM exhibit both osteogenic and angiogenic
properties.
To conclude, the ECM-decorated multiscale porous
scaffolds developed in this study appear to have great potential
to be used as a bone graft substitute. While we used a mouse
cell line in this proof-of-concept study, this technique could be
easily adapted for use with the donated human MSC-derived
ECM to create a product to replace the cadaveric donor bone
graft or patient-specific MSCs to replace the autologous bone
graft. Additionally, it will be interesting to evaluate the
developed biohybrid scaffolds for their use as an in vitro tissue
model mimicking the native bone niche.
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